ReWalk Robotics Hopes to Raise $50M in IPO

From Boston Herald:

A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)

Comments (0)

This post does not have any comments. Be the first to leave a comment below.


Post A Comment

You must be logged in before you can post a comment. Login now.

Featured Product

Discover how human-robot collaboration can take flexibility to new heights!

Discover how human-robot collaboration can take flexibility to new heights!

Humans and robots can now share tasks - and this new partnership is on the verge of revolutionizing the production line. Today's drivers like data-driven services, decreasing product lifetimes and the need for product differentiation are putting flexibility paramount, and no technology is better suited to meet these needs than the Omron TM Series Collaborative Robot. With force feedback, collision detection technology and an intuitive, hand-guided teaching mechanism, the TM Series cobot is designed to work in immediate proximity to a human worker and is easier than ever to train on new tasks.